A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.
Saved in:
| Title: | A pilot study of cerebral metabolism and serotonin 5-HT |
|---|---|
| Authors: | Egger K; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, Bern University Hospital, Bern, Switzerland., Gudmundsen F; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark., Jessen NS; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Baun C; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark., Poetzsch SN; Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland., Shalgunov V; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark., Herth MM; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark., Quednow BB; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland., Martin-Soelch C; Department of Psychology, University Fribourg, Fribourg, Switzerland., Dornbierer D; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Scheidegger M; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland., Cumming P; Department of Nuclear Medicine, Bern University Hospital, Bern, Switzerland.; School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia., Palner M; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.; Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2023 Sep 28; Vol. 14, pp. 1140656. Date of Electronic Publication: 2023 Sep 28 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37841918 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A pilot study of cerebral metabolism and serotonin 5-HT<subscript>2A</subscript> receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Egger+K%22">Egger K</searchLink>; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, Bern University Hospital, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gudmundsen+F%22">Gudmundsen F</searchLink>; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Jessen+NS%22">Jessen NS</searchLink>; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Baun+C%22">Baun C</searchLink>; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Poetzsch+SN%22">Poetzsch SN</searchLink>; Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shalgunov+V%22">Shalgunov V</searchLink>; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Herth+MM%22">Herth MM</searchLink>; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Quednow+BB%22">Quednow BB</searchLink>; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Martin-Soelch+C%22">Martin-Soelch C</searchLink>; Department of Psychology, University Fribourg, Fribourg, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dornbierer+D%22">Dornbierer D</searchLink>; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Scheidegger+M%22">Scheidegger M</searchLink>; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cumming+P%22">Cumming P</searchLink>; Department of Nuclear Medicine, Bern University Hospital, Bern, Switzerland.; School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Palner+M%22">Palner M</searchLink>; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.; Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2023 Sep 28; Vol. 14, pp. 1140656. <i>Date of Electronic Publication: </i>2023 Sep 28 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37841918 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2023.1140656 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1140656 Titles: – TitleFull: A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Egger K – PersonEntity: Name: NameFull: Gudmundsen F – PersonEntity: Name: NameFull: Jessen NS – PersonEntity: Name: NameFull: Baun C – PersonEntity: Name: NameFull: Poetzsch SN – PersonEntity: Name: NameFull: Shalgunov V – PersonEntity: Name: NameFull: Herth MM – PersonEntity: Name: NameFull: Quednow BB – PersonEntity: Name: NameFull: Martin-Soelch C – PersonEntity: Name: NameFull: Dornbierer D – PersonEntity: Name: NameFull: Scheidegger M – PersonEntity: Name: NameFull: Cumming P – PersonEntity: Name: NameFull: Palner M IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 09 Text: 2023 Sep 28 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |
